Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer

Figure 3

Construction of an irlncRNA signature. (a) λ selection by 10-fold cross-validation. The value 0.019 was chosen for λ by 10-fold cross-validation with the minimum criteria. (b) Processes of LASSO Cox model fitting. (c) Univariate and (d) multivariate analysis of the influence of DEirlncRNA pairs in colon cancer patients.

(a)

(b)

(c)

(d)